North Carolina 2025 Session Status: In Committee Bipartisan · 35 D · 1 I · 1 R cosponsors

HB 1127 — Affordable Maternal Access and Cancer Care Act.

Last action — Passed 1st Reading

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill is in committee in the House. Introduced April 29, 2026. It must pass committee before a floor vote.

Next likely step: a committee vote, then a floor vote in the House.

Odds of enactment

Low chance

Based on the sponsor, cosponsors, and committee posture, this bill has a low chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Advancing 42% · moderate confidence

  • In Committee

    Current position in the legislative process.

  • 37 sponsors

    3 primary, 34 co-sponsors signed on.

  • Bipartisan support

    Sponsored across 3 parties (35 D · 1 I · 1 R) — cross-party backing.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

Bill Text

What changed in the latest version

337 added · 335 removed

Plain-language change summary

The recent changes to House Bill 1127 involve the removal of a requirement for applicants to offer programs that align with evidence-based practices. This change simplifies the eligibility criteria for organizations seeking grants under the maternal care access program. It matters because it may allow a wider range of organizations—particularly those with strong community ties but potentially less experience with established evidence-based methods—to access funding and support, ultimately aiming to improve maternal health outcomes in underserved areas.

→
Previous
Latest
GENERAL ASSEMBLY OF NORTH CAROLINA H.B.
GENERAL ASSEMBLY OF NORTH CAROLINA SESSION 2025 H 1 HOUSE BILL 1127 Short Title:
1127 Apr 29, 2026 SESSION 2025 HOUSE PRINCIPAL CLERK H D HOUSE BILL DRH40688-MGa-155C Short Title:Affordable Maternal Access & Cancer Care Act.
Affordable Maternal Access & Cancer Care Act.
Representative Belk.
Representatives Belk, Clark, G.
Brown, and Prather (Primary Sponsors).
For a complete list of sponsors, refer to the North Carolina General Assembly web site.
A BILL TO BE ENTITLED AN ACT ENACTING THE AFFORDABLE MATERNAL ACCESS AND CANCER CARE ACT TO ESTABLISH AND FUND A MATERNAL CARE ACCESS GRANT PROGRAM AND A PROSTATE CANCER CONTROL PROGRAM;
Appropriations, if favorable, Rules, Calendar, and Operations of the House April 30, 2026 A BILL TO BE ENTITLED AN ACT ENACTING THE AFFORDABLE MATERNAL ACCESS AND CANCER CARE ACT TO ESTABLISH AND FUND A MATERNALCARE ACCESS GRANT PROGRAM AND A PROSTATE CANCER CONTROL PROGRAM;
– Sensitive to and respectful of the preferred cultural values, beliefs, world view, and practices of the patient, and aware that cultural differences between patients and health care providers or other service providers must be proactively addressed to ensure that patients receive equitable, high-quality services that meet their needs.
– Sensitive to and respectful of the preferred cultural values, beliefs, world view, and practices of the patient, and aware that cultural differences between patients and health care providers or other service providers must be proactivelyaddressed to ensure that patients receive equitable, high-quality services that meet their needs.
The Department shall establish eligibility requirements for program participation which shall, at a minimum, *DRH40688-MGa-155C* General Assembly Of North Carolina Session 2025 require that applicants be organizations led by individuals from communities that have historically experienced disparities in accessing health and human services.
The Department *H1127-v-1* General Assembly Of North Carolina Session 2025 shall establish eligibility requirements for program participation which shall, at a minimum, require that applicants be organizations led by individuals from communities that have historically experienced disparities in accessing health and human services.
c.
Page 2 House Bill 1127-First Edition General Assembly Of North Carolina Session 2025 c.
Page 2 DRH40688-MGa-155C General Assembly Of North Carolina Session 2025 d.
d.
(1) A report by October 1, 2027, that includes at least all of the following components:
House Bill 1127-First Edition Page 3 General Assembly Of North Carolina Session 2025 (1) A report by October 1, 2027, that includes at least all of the following components:
DRH40688-MGa-155C Page 3 General Assembly Of North Carolina Session 2025 b.
b.
Recommendations for future grant programs to be administered by the Department and for future funding opportunities for community-based organizations to improve maternal health outcomes for marginalized and underserved populations through programs and resources that are aligned with evidence-based practices for improving maternal health outcomes for marginalized and underserved populations.
Recommendations for future grant programs to be administered bythe Department and for future fundingopportunities for community-based organizations to improve maternal health outcomes for marginalized and underserved populations through programs and resources that are aligned with evidence-based practices for improving maternal health outcomes for marginalized and underserved populations.
SECTION 3.2.
Page 4 House Bill 1127-First Edition General Assembly Of North Carolina Session 2025 SECTION 3.2.
Page 4 DRH40688-MGa-155C General Assembly Of North Carolina Session 2025 (a) The following definitions apply in this section:
(a) The following definitions apply in this section:
(8) Screening of earlydetectionofcervical cancer.
(8) Screeningof earlydetectionofcervical cancer.
–Examinations and laboratory tests used to detect cervical cancer, including conventional PAP smear screening, liquid-based cytology,andhumanpapillomavirus(HPV) detection methods for women with equivocal findings on cervical cytologic analysis that aresubject to theapproval ofandhavebeenapprovedbytheUnitedStates Food and Drug Administration.
–Examinations andlaboratory tests used to detect cervical cancer, including conventional PAP smear screening, liquid-based cytology,and humanpapilloma virus (HPV) detection methods for women with equivocal findings on cervical cytologic analysis that aresubject to theapproval ofandhavebeenapprovedbytheUnitedStates Food and Drug Administration.
58-50-56, thatis issued,renewed, oramended on orafterJanuary1,1992, health benefit plan offered by an insurer in this State shall provide coverage for examinations and laboratory tests for the screening for the early detection of cervical cancer and for low-dose screening mammography.
58-50-56, thatis issued,renewed, oramended on orafterJanuary1,1992, health benefit plan offered by an insurer in this State shall provide coverage for examinations and laboratory tests for the screening for the early detection of cervical cancer and for low-dose House Bill 1127-First Edition Page 5 General Assembly Of North Carolina Session 2025 screening mammography.
DRH40688-MGa-155C Page 5 General Assembly Of North Carolina Session 2025 (a1) As used in this section, "examinations and laboratory tests for the screening for the early detection of cervical cancer" means conventional PAP smear screening, liquid-based cytology, and human papilloma virus (HPV) detection methods for women with equivocal findings on cervical cytologic analysis that are subject to the approval of and have been approved by the United States Food and Drug Administration.
(a1) As used in this section, "examinations and laboratory tests for the screening for the early detection of cervical cancer" means conventional PAP smear screening, liquid-based cytology, and human papilloma virus (HPV) detection methods for women with equivocal findings on cervical cytologic analysis that are subject to the approval of and have been approved by the United States Food and Drug Administration.
(b) As used in this section, "low-dose screening mammography" means a radiologic procedure for the early detection of breast cancer provided to an asymptomatic woman using equipment dedicated specifically for mammography, including a physician's interpretation of the results of the procedure.
(b) As used in this section, "low-dose screening mammography" means a radiologic procedure for the early detection of breast cancer provided to an asymptomatic woman using equipment dedicated specificallyfor mammography, including a physician's interpretation of the results of the procedure.
Reimbursements for laboratory fees shall be made only if the laboratory meets accreditation standards adopted by the North Carolina Medical Care Commission.
Page 6 House Bill 1127-First Edition General Assembly Of North Carolina Session 2025 Reimbursements for laboratory fees shall be made only if the laboratory meets accreditation standards adopted by the North Carolina Medical Care Commission.
(f) If the application of any provision of this section would render the insured ineligible for a health savings account under section 223, then that provision shall apply only for high-deductible health plans with respect to the deductible of that plan after the insured has Page 6 DRH40688-MGa-155C General Assembly Of North Carolina Session 2025 satisfied the minimum deductible under section 223, except with respect to items or services that are preventive care.
(f) If the application of any provision of this section would render the insured ineligible for a health savings account under section 223, then that provision shall apply only for high-deductible health plans with respect to the deductible of that plan after the insured has satisfied the minimum deductible under section 223, except with respect to items or services that are preventive care.
Thefollowing provisionsofChapter58oftheGeneral Statutesapply to theStateHealthPlan:
Thefollowingprovisions ofChapter58oftheGeneral Statutesapplyto theStateHealthPlan:
(8) Insurer.
House Bill 1127-First Edition Page 7 General Assembly Of North Carolina Session 2025 (8) Insurer.
(a) A healthcare provider who has not contracted with an insurer to participate in the provider network of a health benefit plan shall accept as reimbursement for any breast cancer prevention service provided to an individual insured under a health benefit plan the amount of DRH40688-MGa-155C Page 7 General Assembly Of North Carolina Session 2025 reimbursement provided by that insurer, including any cost-sharing required to be paid by the patient.
(a) A healthcare provider who has not contracted with an insurer to participate in the provider network of a health benefit plan shall accept as reimbursement for any breast cancer prevention service provided to an individual insured under a health benefit plan the amount of reimbursement provided by that insurer, including any cost-sharing required to be paid by the patient.
Page 8 DRH40688-MGa-155C
Page 8 House Bill 1127-First Edition
⬇ Download PDF
View plain text versions (2)

Action History

  1. Passed 1st Reading

  2. Ref to the Com on Appropriations, if favorable, Rules, Calendar, and Operations of the House

  3. Filed

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

3 sponsors · 34 co-sponsors · 142 not signed on

Sponsors (3)

Co-sponsors (34)

Not signed on (142)

142 members have not signed on to this bill.

Show all 142 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

veterans healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

Who sponsors HB 1127?
HB 1127 is sponsored by Brian Turner (Democratic), Phil Rubin (Democratic), James Roberson (Democratic), Robert T. Reives, II (Democratic), Amos L. Quick, III (Democratic), Renée A. Price (Democratic), Rodney D. Pierce (Democratic), Marcia Morey (Democratic), Nasif Majeed (U), Jordan Lopez (Democratic), Carolyn G. Logan (Democratic), Monika Johnson-Hostler (Democratic), B. Ray Jeffers (Democratic), Julie von Haefen (Democratic), Zack Hawkins (Democratic), Pricey Harrison (Democratic), Julia Greenfield (Democratic), Allison A. Dahle (Democratic), Amanda P. Cook (Democratic), Mike Colvin (Democratic), Bryan Cohn (Democratic), Becky Carney (Democratic), Deb Butler (Democratic), Allen Buansi (Democratic), Terry M. Brown Jr. (Democratic), Kanika Brown (Democratic), Cynthia Ball (Democratic), Amber M. Baker (Democratic), Vernetta Alston (Democratic), Eric Ager (Democratic), Lindsey Prather (Democratic), Gloristine Brown (Democratic), Tracy Clark (Democratic), Mary Belk (Democratic), Beth Helfrich (Democratic), Neal Jackson (Republican), and Charles Smith (Democratic).
What is the current status of HB 1127?
This bill is in committee in the House. Introduced April 29, 2026. It must pass committee before a floor vote.
Where can I track HB 1127?
Track HB 1127 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB 1127

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HB 1127

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →